Asthma is a heterogeneous disease that in children is often allergen-driven with a type 2 inflammation. Sublingual immunotherapy represents an important progress in the use of personalized medicine in children with allergic asthma. It is a viable option for house dust mite-driven asthma and in subjects with the asthma associated with allergic rhinitis. The use and indications for isolated asthma caused by other allergens are still controversial owing to heterogeneity of commercially available products and methodological limitations of studies in children. Nevertheless, most studies and meta-analyses found the efficacy of sublingual immunotherapy. Sublingual immunotherapy is safe but cannot be recommended in children with uncontrolled asthma.

Use of Sublingual Immunotherapy for Aeroallergens in Children with Asthma / Caffarelli, Carlo; Mastrorilli, Carla; Procaccianti, Michela; Santoro, Angelica. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:10(2020), p. 3381. [10.3390/jcm9103381]

Use of Sublingual Immunotherapy for Aeroallergens in Children with Asthma

Caffarelli, Carlo
;
Procaccianti, Michela;Santoro, Angelica
2020-01-01

Abstract

Asthma is a heterogeneous disease that in children is often allergen-driven with a type 2 inflammation. Sublingual immunotherapy represents an important progress in the use of personalized medicine in children with allergic asthma. It is a viable option for house dust mite-driven asthma and in subjects with the asthma associated with allergic rhinitis. The use and indications for isolated asthma caused by other allergens are still controversial owing to heterogeneity of commercially available products and methodological limitations of studies in children. Nevertheless, most studies and meta-analyses found the efficacy of sublingual immunotherapy. Sublingual immunotherapy is safe but cannot be recommended in children with uncontrolled asthma.
2020
Use of Sublingual Immunotherapy for Aeroallergens in Children with Asthma / Caffarelli, Carlo; Mastrorilli, Carla; Procaccianti, Michela; Santoro, Angelica. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:10(2020), p. 3381. [10.3390/jcm9103381]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2885751
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 5
social impact